当前位置:
首页 > 技术文章 > 朝藿定B 分析标准品,HPLC≥98%
目录导航 Directory
技术支持Article
朝藿定B 分析标准品,HPLC≥98%
点击次数:19 更新时间:2026-02-10

朝藿定B

分析标准品,HPLC≥98%

Epimedin B

CAS号:110623-73-9

分子式:C38H48O19

分子量:808.78

MDLMFCD04039834

别名:朝藿定 B; 朝藿定B;;Epimedin?B; Epmedin B

货号

规格/参数/品牌

价格

货期

YJ-B20172-10mg

分析标准品,HPLC≥98%

700.00

现货

YJ-B20172-20mg

分析标准品,HPLC≥98%

1100.00

现货

 

产品介绍

熔点:162-164 ℃

沸点:1066.1℃ at 760 mmHg

外观:黄色粉末

溶解性:DMSO  :  33.33  mg/mL  (41.21  mM;  Need  ultrasonic)

储存条件:2-8℃

注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献(39)

39. [IF=3.8] Jialu Shen et al."Insights into inhibitory mechanisms: Unraveling the structure-activity relationship of dietary flavonoids on gut bacterial β-glucuronidase."Journal of Functional Foods.2024 Nov;122:106510

38. [IF=2.5] Zheng Junzuo et al."Pharmacokinetics of seven major components in Aβ1-42-treated rats after oral administration of an aqueous extract of Curculiginis Rhizoma and Epimedii Folium."Journal of Natural Medicines.2024 Nov;:1-16

37. [IF=4.3] Yang Linlin et al."Spraying methyl jasmonate before harvesting can significantly increase the content of icariin in an important leaf medicinal herb, Epimedium sagittatum, by activating the expression of genes involved in flavonoid synthesis pathways."BMC

36. [IF=6.7] Xinguang Liu et al."Screening effective-component compatibility from Jinshui Chenfei formula for silicosis treatment by serum-pharmacochemistry and feedback system control."PHYTOMEDICINE.2025 Mar;138:156419

35. [IF=4.4] Chen Yangfeng et al."In Vitro evaluation of the anti-pancreatic cancer activity of epimedium herb."Frontiers in Pharmacology.2024 Jul;15:

34. [IF=4.9] Zheyuan Shen et al."Rapid evaluation of the quality of Epimedium with different processing degrees by E-eye and NIR spectroscopy combined with machine learning."MICROCHEMICAL JOURNAL.2024 Oct;205:111181

33. [IF=4.7] Li Liu et al."Epimedin B exerts an anti-inflammatory effect by regulating the MAPK/NF-κB/NOD-like receptor signalling pathways."FISH & SHELLFISH IMMUNOLOGY".2024 Jul;150:109657

32. [IF=5.4] Yi-min Liu et al."Uncovering the key pharmacodynamic material basis and possible molecular mechanism of extract of Epimedium against liver cancer through a comprehensive investigation."JOURNAL OF ETHNOPHARMACOLOGY.2023 Dec;317:116765

31. [IF=5.572] Zhen Zhao et al."An integrated strategy combining network toxicology and feature-based molecular networking for exploring hepatotoxic constituents and mechanism of Epimedii Folium-induced hepatotoxicity in vitro."FOOD AND CHEMICAL TOXICOLOGY.2023 Jun;176:

30. [IF=6.208] Jiaqi Zhang et al."The Effect of Epimedium Isopentenyl Flavonoids on the Broiler Gut Health Using Microbiomic and Metabolomic Analyses."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2023 Jan;24(8):7646

29. [IF=6.352] Lin Yu et al."Highly efficient bioconversion of icariin to icaritin by whole-cell catalysis."Microbial Cell Factories.2023 Dec;22(1):1-11

28. [IF=6.208] Yu Yao et al."A Novel 3-O-rhamnoside: 2″-O-xylosyltransferase Responsible for Terminal Modification of Prenylflavonol Glycosides in Epimedium pubescens Maxim.."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2022 Jan;23(24):16050

27. [IF=1.698] Jinyan Wu et al."Chemical Identification and Antioxidant Screening of Bufei Yishen Formula using an Offline DPPH Ultrahigh-Performance Liquid Chromatography Q-Extractive Orbitrap MS/MS."International Journal of Analytical Chemistry.2022 Oct 15;2022:142380

26. [IF=6.208] Pan Wang et al."Discovery of Flavonoids as Novel Inhibitors of ATP Citrate Lyase: Structure–Activity Relationship and Inhibition Profiles."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2022 Jan;23(18):10747

25. [IF=5.988] Qihan Luo et al."Chang qing formula ameliorates colitis-associated colorectal cancer via suppressing IL-17/NF-κB/STAT3 pathway in mice as revealed by network pharmacology study."Frontiers in Pharmacology.2022; 13: 893231

24. [IF=4.996] Yuan Jie et al."Systematic characterization of the components and molecular mechanisms of Jinshui Huanxian granules using UPLC-Orbitrap Fusion MS integrated with network pharmacology."Scientific Reports.2022 Jul;12(1):1-24

23. [IF=5.988] Li  Pin et al."Epimedium koreanum Nakai–Induced Liver Injury—A Mechanistic Study Using Untargeted Metabolomics."Frontiers in Pharmacology.2022 Jul;0:2288

22. [IF=3.361] Yuhao Zhang et al."An integrated approach for structural characterization of Gui Ling Ji by traveling wave ion mobility mass spectrometry and molecular network."Rsc Adv. 2021 Apr;11(26):15546-15556

21. [IF=3.757] Congyan Liu et al."Enhanced hydrolysis and antitumor efficacy of Epimedium flavonoids mediated by immobilized snailase on silica."Process Biochem. 2019 Nov;86:80

20. [IF=4.411] Zhenxian Qin et al."A Widely Metabolomic Analysis Revealed Metabolic Alterations of Epimedium Pubescens Leaves at Different Growth Stages."Molecules. 2020 Jan;25(1):137

19. [IF=4.545] Yan-dan Zhou et al."Icariin ameliorates cisplatin-induced cytotoxicity in human embryonic kidney 293 cells by suppressing ROS-mediated PI3K/Akt pathway."Biomed Pharmacother. 2019 Jan;109:2309

18.  Zhou, Yan-dan, et al. "Icariin ameliorates cisplatin-induced cytotoxicity in human embryonic kidney 293 cells by suppressing ROS-mediated PI3K/Akt pathway." Biomedicine & Pharmacotherapy 109 (2019): 2309-2317.https:##doi.org/10.1016/j.biopha.2018.11.108

17.  吴嫣艳,任会旭,冯友龙,张莉,张妤琳.安神补脑胶囊HPLC指纹图谱与3种成分含量测定方法研究[J].广东药科大学学报,2020,36(06):778-783.

16.  黄楷迪,刘敬霞,牛阳,马学琴,张婷,卜凡淑,任慧,郭盛,钱大玮,段金廒.回药扎里奴思方UPLC指纹图谱结合多成分含量测定的质控方法研究[J].南京中医药大学学报,2021,37(01):77-82.

15.  许婷,黄萌萌,李瑞云,杨茹,刘丽芳,陈彦.多基原淫羊藿不同部位质量评价研究[J].中草药,2020,51(01):190-196.

14.  兰海,刘欣妍,余玲,莫诺兰,张燕,郭子右,吴清.大孔树脂纯化淫羊藿中朝藿定与淫羊藿苷工艺研究[J].中草药,2020,51(17):4473-4481.

13.  杨成梓  范兴  包侠萍 等. HPLC同时测定芪骨胶囊中5种成分的含量[J]. 中国实验方剂学杂志  2015  021(016):60-63.

12.  彭静, 马益华, 陈彦,. 固定化蜗牛酶同时生物转化淫羊藿中4种黄酮苷[J]. 中成药, 2016, 38(9):1984-1990.

11.  高霞, 陈彦, 王莹,. 糊精湿法制粒对淫羊藿总黄酮酶解的影响[J]. 中成药, 2014, 36(007):1392-1397.

10.  高霞, 刘璇, 陈彦,. 淫羊藿总黄酮的生物转化过程分析[J]. 中国中药杂志, 2013, 38(23):4079.

9.  刘聪燕, 高霞, 陈彦,. 淫羊藿总黄酮在骨质疏松大鼠体内的药动学行为[J]. 中成药, 2017, 39(008):1595-1600.

8.  刘聪燕, 高霞, 黄萌萌,. 淫羊藿总黄酮仿生酶解肠溶胶囊的制备及评价[J]. 中草药, 2016(20).

7.  姜新刚, 贾继明, 李叶双. 津力达颗粒UPLC指纹图谱[J]. 中国实验方剂学杂志, 2013, 19(001):126-129.

6.  张燕. 大孔吸附树脂分离纯化淫羊藿EF5黄酮[J]. 北方药学, 2015, 000(011):11-13.

5.  李婧,王英哲,刘玉翠,景志贤,闫莉,郭俊杰,姜大成,肖井雷.地理环境因子对朝鲜淫羊藿黄酮类成分空间分布影响的探测分析[J].中国中药杂志,2019,44(24):5368-5374.

4.  刘聪燕  高霞  陈彦 等. 仿生酶解肠溶胶囊提高淫羊藿总黄酮口服生物利用度的可行性研究[J]. 中国医药工业杂志  2016(9):1158-1164.

3.  王英哲 姜大成 容路生 肖井雷 张强 翁丽丽.东北产朝鲜淫羊藿中黄酮类成分的对比分析[J].药物分析杂志 2019 39(11):2034-2040.

2.  范兴, 杨成梓, 包侠萍,. 芪骨胶囊HPLC指纹图谱研究[J]. 中草药, 2014, 045(009):1257-1261.

1.  王莹  高霞  陈彦 等. 卡波姆对淫羊藿总黄酮酶解效果的影响[J]. 中国实验方剂学杂志  2014  20(009):1-5.

2011年开始我们致力于在生命科学领域生物医学实验技术及论文润色服务,协助客户各类实验服务及论文润色十余年,是客户您值得信赖的科研合作伙伴!

如果您受时间、试验条件等限制而无法完成您的课题研究,欢迎您与我们联系。

 

实验技术服务:

 


沪公网安备 31011802001678号